Literature DB >> 16143896

Colitis and colony-stimulating factors (CSFs): is stimulation of innate immunity through CSFs really effective for the treatment of chronic colitis?

Kazuyoshi Nagayama, Mamoru Watanabe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16143896     DOI： 10.1007/s00535-005-1673-1

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN： 0944-1174            Impact factor:   7.527


× No keyword cloud information.
  7 in total

Review 1.  Is Crohn's disease an immunodeficiency? A hypothesis suggesting possible early events in the pathogenesis of Crohn's disease.

Authors:  J R Korzenik; B K Dieckgraefe
Journal:  Dig Dis Sci       Date:  2000-06       Impact factor: 3.199

Review 2.  Basic biology of the hematopoietic growth factors.

Authors:  P S Crosier; S C Clark
Journal:  Semin Oncol       Date:  1992-08       Impact factor: 4.929

3.  Interleukin-17 augments tumor necrosis factor-alpha-induced granulocyte and granulocyte/macrophage colony-stimulating factor release from human colonic myofibroblasts.

Authors:  Akira Andoh; Hirofumi Yasui; Osamu Inatomi; Zhuobin Zhang; Yasuyuki Deguchi; Kazunori Hata; Yoshio Araki; Tomoyuki Tsujikawa; Katsuyuki Kitoh; Shokei Kim-Mitsuyama; Atsushi Takayanagi; Nobuyoshi Shimizu; Yoshihide Fujiyama
Journal:  J Gastroenterol       Date:  2005-08       Impact factor: 7.527

4.  Treatment of active Crohn's disease with recombinant human granulocyte-macrophage colony-stimulating factor.

Authors:  Brian K Dieckgraefe; Joshua R Korzenik
Journal:  Lancet       Date:  2002-11-09       Impact factor: 79.321

Review 5.  Interleukin 17: an example for gene therapy as a tool to study cytokine mediated regulation of hematopoiesis.

Authors:  Paul Schwarzenberger; Jay K Kolls
Journal:  J Cell Biochem Suppl       Date:  2002

6.  A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease.

Authors:  Y Ogura; D K Bonen; N Inohara; D L Nicolae; F F Chen; R Ramos; H Britton; T Moran; R Karaliuskas; R H Duerr; J P Achkar; S R Brant; T M Bayless; B S Kirschner; S B Hanauer; G Nuñez; J H Cho
Journal:  Nature       Date:  2001-05-31       Impact factor: 49.962

7.  Increased production of granulocyte-macrophage colony-stimulating factor in Crohn's disease--a possible target for infliximab treatment.

Authors:  Jørgen Agnholt; Jens Kelsen; Birgitte Brandsborg; Niels O Jakobsen; Jens F Dahlerup
Journal:  Eur J Gastroenterol Hepatol       Date:  2004-07       Impact factor: 2.566
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.